Dr James Wilson - Lung Cancer Specialist UK

Dr James Wilson - Lung Cancer Specialist UK Stop waiting. Get clarity from a leading UK lung cancer specialist. Fast access to personalised treatment for all stages. End the uncertainty and take control.

Book a consultation within 48 hours - expert answers, honest options, personal care. Dr James Wilson is a London-based private oncologist with expertise in lung cancer, skin cancer, and advanced radiotherapy for Stage 4 cancers. He offers rapid access to chemotherapy, immunotherapy, targeted therapy, and precision radiotherapy - including proton beam therapy. Known for clear communication and pers

onalised care, Dr Wilson helps patients take control with expert second opinions and tailored treatment plans. Appointments are often available within days, either in person or via video. Video consultations are often possible on the same or next day. Trusted by patients
Specialist in complex and advanced cases
Precision-led, consultant-delivered care

08/06/2026

Most people assume the CT scan tells their team everything they need.

It doesn’t.

A CT shows where the cancer is. A PET scan shows whether it’s active, spreading, essentially how it’s behaving.

It works by tracking sugar. Cancer cells are far hungrier than healthy tissue, so they consume more and light up on the scan.

What the process looks like:

1. An injection of radioactive sugar, then an hour of rest while it moves through your body.

2. Around 30 minutes lying still in the scanner.

No pain. Nothing enclosed.

What your team learns from it changes everything about treatment planning.

Whether the cancer has reached lymph nodes or other organs.

Whether it’s behaving slowly or quickly.

Whether treatment needs to stay local or work across your whole body.

The best result is a scan that only lights up where you already knew the cancer was.

After this, the next step is usually a brain scan, because the PET doesn’t image that area reliably enough on its own.

Any questions about what this means for you or a loved one, send me a DM or an email.

07/06/2026

Another oncologist asked me what my standard first-line treatment is for EGFR-mutated lung cancer.

My answer probably annoyed him. I don’t have one. It’s always a conversation.

Three options for stage 4 EGFR-mutated lung cancer:

Osimertinib alone. Osimertinib combined with chemotherapy (FLAURA2 trial). Or amivantamab and lazertinib together (MARIPOSA trial).

The combinations offer a survival advantage. But which one is right depends on you: your upcoming life events, the side effects, what matters most right now.

When does chemotherapy become close to essential?

If your biopsy shows both an EGFR mutation and a TP53 mutation, the data are hard to ignore.

A new phase three study showed that combining osimertinib with chemotherapy more than doubled progression-free survival in this group: roughly 34 months versus 16 months. Deeper responses. Longer-lasting. Even in patients with brain metastases.

For me, if someone has both mutations, I need a good reason not to recommend the combination. Undertreating this group may be worse than the side effects.

What if you have a HER2 mutation instead?

HER2 is rare, only a small percent of non-small cell lung cancer patients. And until recently, outcomes weren’t great. Response to chemotherapy was measured in months.

A new drug called zongertinib has doubled the response rate in this group for patients who haven’t yet had any treatment.

Whatever treatment you’re on, always have the next step in mind:

First-line is where we see the biggest, longest responses. After that, returns diminish with each line.

Data just presented at the ELCC on a drug called gotistobart shows real promise at second line.

It doesn’t attack the cancer directly, it targets the white blood cells inside the tumour that are blocking your immune system from working. Median response time of 11 months, compared to under four months for the current standard.

It’s not available in the UK yet. But if you’re on chemo-immunotherapy now, use that time. Look at what trials are open. Know what your next step might be.

If you have questions about EGFR mutated lung cancer, send me a DM or an email.

06/06/2026

After a cancer diagnosis, the wait before your first oncology appointment can feel endless.

Most of the time, that delay exists because we’re waiting for molecular profiling, genetic testing that usually takes two to three weeks.

I get why that feels frustrating.

What you don’t have to wait for:

A conversation with a private oncologist now. Before the results arrive. Before treatment starts.

That single meeting can do several things: give you clarity on what your likely options are, help you prepare the right questions for when results come back, and paint a realistic picture of what happens next.

That matters far more than sitting in uncertainty.

How to spend these weeks productively:

This isn’t dead time before treatment. Most patients can genuinely improve their position by starting now.

Rebuild your fitness. Get your nutrition sorted. Start learning what treatment actually involves.

These things shape how you handle treatment and how quickly you bounce back afterwards.

The point:

You don’t need test results to get answers.

You need a conversation.

If you’ve just been diagnosed and want to talk through your situation before the standard pathway kicks in, send me a DM or email me.

03/06/2026

How does radiotherapy actually stop lung cancer from growing?

The mechanism:

Radiotherapy delivers focused beams of high-energy X-rays directly to the tumour.

At a cellular level, these beams damage the DNA structure inside cancer cells, preventing them from multiplying.

Why we spread the treatment over weeks:

The surrounding healthy tissue is affected during each session, but it recovers between treatments far more effectively than cancer can.

By delivering smaller doses daily, we build cumulative damage that cancer cells cannot repair. Your normal lungs get time to heal between sessions.

Why this works in practice:

About half of all cancer patients receive radiotherapy at some point.

For lung cancer specifically, it’s one of the most reliable tools we have: whether the goal is cure, controlling local disease, or managing symptoms.

We’ve refined these techniques over decades.

Still got questions about whether radiotherapy might be right for your lung cancer? Get in touch via DM or email.

Are MDT meetings delaying your cancer treatment?MDT stands for multidisciplinary team meeting. It is a weekly meeting wh...
02/06/2026

Are MDT meetings delaying your cancer treatment?

MDT stands for multidisciplinary team meeting. It is a weekly meeting where doctors from different specialities come together to discuss patient cases and agree on the next steps in treatment.

In principle, they are essential. They are there to ensure you get the best care, regardless of which specialist you happened to see first.

But I am seeing a problem.

More and more patients are waiting for the MDT before any decision is made, including basic ones. Things we already know the answer to.

If a chest x-ray suggests lung cancer, there are five tests needed quickly. A meeting a week later to agree on that is a delay, not a safeguard.

The MDT is there for quality and for complex cases. It is not there to be the gatekeeper for every next step.

If you are being told to wait for the MDT before anything moves:

Ask your team what can happen between now and that meeting.

If you know a referral to another specialist is coming, ask if it can be made now, before the MDT takes place.

You are not being difficult. You are getting the care you deserve.

If this is happening to you or a loved one, send me a DM or an email.

30/05/2026

One of the many questions I get asked when discussing radiotherapy with patients: “Is radiotherapy really doing anything?”

You’re lying there. The machine moves around you.

You don’t see anything. You don’t feel anything.

So let me explain what’s actually happening in the hopes of answering this question and several other common questions that come up:

Radiotherapy is completely painless.
It feels like having an X-ray.
The beams pass through your body without you feeling a thing.

No heat. No tingling. Nothing.

But the treatment is working:

We’re targeting your tumour with millimetre accuracy.

Getting as much radiation as possible into the cancer.

While reducing the dose to the healthy parts of you.

What you will notice:

You won’t feel the treatment itself.

But over the course of your radiotherapy, some symptoms will start to creep in.

That’s normal. That’s the treatment doing its job.

If you’re going through lung cancer treatment discussions save these questions and bring them to your next appointment.

And if you’d like to discuss anything directly feel free to send me a DM or an email.

Does your age alone decide your cancer treatment?If you’re over 80 and you’ve been told surgery isn’t an option, that ma...
28/05/2026

Does your age alone decide your cancer treatment?

If you’re over 80 and you’ve been told surgery isn’t an option, that may not be the whole picture.

→ What I see in clinic:

I had two patients this week, both over 80, both with early stage lung cancer.

Both surprised when I recommended surgery.

Why age isn’t the deciding factor:

Treatment decisions should never be based on age alone.

What we look at is the full picture: your other health conditions, your risk of complications, and how fit you are day to day.

What the data shows:

Research from Mount Sinai in New York (2026) looked at patients over 80 and compared them with younger patients.

Five year survival and risk of cancer returning were the same in both groups.

Early complications were slightly higher in the over 80s, and that’s part of the conversation we have.

But long term outcomes were comparable.

What this means for you:

If you or a loved one are over 80 and have been told surgery isn’t suitable, it’s worth asking why.

Age alone is not a reason to rule it out.

If you’d like to talk through your options, send me a DM or an email.

27/05/2026

Is radiotherapy really doing anything?

You’re lying there. The machine moves around you.
You don’t see anything. You don’t feel anything.

Here’s what’s actually happening:

Radiotherapy is completely painless.

It feels like having an X-ray.
The beams pass through your body without you feeling a thing.

No heat. No tingling. Nothing.

But the treatment is working:

We’re targeting your tumour with millimetre accuracy.
Getting as much radiation as possible into the cancer.
While reducing the dose to the healthy parts of you.

What you will notice:

You won’t feel the treatment itself.
But over the course of your radiotherapy, some symptoms will start to creep in.

That’s normal. That’s the treatment doing its job.

If you’re going through lung cancer treatment and have questions about what to expect, send me a DM.

26/05/2026

Why are you being asked to wait weeks before meeting your oncologist?

It’s a question I hear all the time.

→ The standard pathway

After a cancer diagnosis, most patients wait for molecular profiling results before seeing an oncologist.

That can take two to three weeks.

And I understand why the system works that way. That information matters.

But you don’t have to spend those weeks in the dark.

→ What a single consultation can do

A conversation with a private oncologist can give you a clear picture of what your options are likely to be.

What questions to ask when the results come in.
What the road ahead might look like.

→ That window isn’t wasted time

There’s often a great deal you can do before treatment starts.

- Working on your fitness.
- Optimising your nutrition.
- Understanding what to expect.

All of it can genuinely affect how well you tolerate treatment and how quickly you recover.

If you’ve just been diagnosed and have questions, send me a DM or email.

22/05/2026

I have been thinking carefully recently about how I share survival data with my patients.

And whether the way we currently do it is actually as helpful as it could be.

Why the median figure only tells part of the story:

When a patient with metastatic cancer starts a new treatment, I can share data from the clinical trial that informed that decision.

The most common way oncologists present that data is the median: the outcome for the person right in the middle of the pack.

But the median only tells you about one point on that curve.

Plenty of people did considerably better. Some unfortunately did worse.

What the full picture actually looks like:

At one end, particularly with immunotherapy, we are seeing a proportion of patients living for a very long time with stage 4 cancer. Typically around 10 to 15%.

That tail on the survival curve can be quite extended.

At the other end, around 10% of patients progress quickly. The median tells you neither of those things.

Where I think the conversation needs to go:

I am increasingly drawn to presenting the middle 50% of outcomes. What happens for patients at the 25th and 75th percentile, as a range rather than a single number.

That gives a more honest picture of what treatment might look like for any individual.

But perhaps the more important shift is simply this: oncologists should be asking patients directly how they want to receive this information.

What data is helpful to you?
What would support you in making this decision?

Every patient is different, and the information that feels empowering to one person can feel overwhelming to another.

What you can do right now:

As a patient, you can ask your oncologist for this data directly. You are entitled to understand the full range of outcomes from the trial that your treatment is based on, not just the median. That way you can make a genuinely informed decision about starting treatment.

If you would like to talk through what survival data means for your specific situation, send me a DM or an email.

Address

Services Available In:
London
SW50TU

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+442079936716

Website

Alerts

Be the first to know and let us send you an email when Dr James Wilson - Lung Cancer Specialist UK posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Dr James Wilson - Lung Cancer Specialist UK:

Shortcuts

Share